UCTT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. UCTT just had a sharp -8.02% regular-session drop to the low-$43s, and while the bigger-picture moving-average structure remains bullish, momentum is fading (MACD positive but contracting) and price is now below the pivot (45.263) and sitting just above first support (S1 ~42.803). With no Intellectia AI Stock Picker or SwingMax buy signal today, elevated put-volume skew (bearish/hedging) and a notable increase in insider selling, the risk/reward for an impatient buyer is not favorable at this moment. A better “buy-now” setup would require a clean hold-and-bounce off ~42.8 (S1) with strength back above ~45.3 (pivot), or a fresh proprietary signal.
Trend/structure: Bullish longer-term structure with SMA_5 > SMA_20 > SMA_200, implying the stock has been in an uptrend on moving averages.
Momentum: MACD histogram is +0.0948 (still positive) but “positively contracting,” signaling upside momentum is weakening after the recent selloff. RSI(6) 51.2 is neutral, not showing an oversold condition that would typically support an immediate dip-buy.
Levels: Price (43.2 post-market) is below Pivot 45.263 (a near-term bearish sign) and is hovering just above S1 42.803. If S1 fails, next downside reference is S2 41.283. Upside hurdles are 45.263 first, then R1 47.723.
Near-term pattern stats provided: modest expected drift (next week +1.3%) but not strong enough to offset the current breakdown risk for an immediate entry.
Analyst support: Needham reiterated Buy and raised PT to $50 (from $
on 2026-01-20, citing broad-based demand improvement and potential Q4-related catalysts.
Earnings catalyst: QDEC 2025 earnings scheduled 2026-02-23 after hours (Street EPS est. 0.16). A positive print or upbeat commentary on semicap demand could re-rate the stock.
COO successor profile: Incoming COO Robert Wunar has deep semicap experience, which could improve execution/efficiency over time.
Sharp price damage: -8.02% regular-session drop increases the chance of follow-through selling, especially if ~42.8 support breaks.
Insider selling: Insiders are selling, with selling amount up ~187.88% over the last month—an unfavorable near-term signal.
Management transition risk: COO departure (effective Jan
and delayed start for replacement (Mar
can create execution uncertainty.
Options flow turned defensive: Put-heavy volume suggests traders are hedging or betting on more downside into the next catalyst window.
Financial pressure: Revenue and gross margin are trending down YoY (see financials), limiting fundamental “buy-the-dip” conviction right now.
Latest reported quarter: 2025/Q3. Growth trends: Revenue fell to $510M, down -5.63% YoY, indicating top-line softness. Gross margin declined to 16.12 (down -6.71% YoY), showing profitability pressure. Bottom line: Net income improved to -$10.9M (still a loss, but significantly better YoY), and EPS improved to -0.24 (also still negative). Overall: losses are narrowing, but the business is not yet showing clean, broad-based growth—especially with weakening revenue and margins.
Recent trend: The notable update is Needham (2026-01-20) maintaining a Buy while raising its price target sharply to $50 from $35, citing improving demand over the past ~90 days and expecting Q4-related catalysts. Wall Street pro view (pros/cons): Pros—improving semicap demand signals, potential earnings catalysts, and a materially higher PT implies perceived upside. Cons—the market just repriced the stock downward sharply, fundamentals show YoY revenue and margin pressure, and insider selling is elevated. Influential/politician activity: No recent congress trading data available in the last 90 days (no signal from politician trades). Intellectia Proprietary Trading Signals:
